RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Robert Kirken to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications Robert Kirken has written about Xenograft Model Antitumor Assays.
Robert Kirken
Connection Strength
0.018
Xenograft Model Antitumor Assays
  1. Dagvadorj A, Kirken RA, Leiby B, Karras J, Nevalainen MT. Transcription factor signal transducer and activator of transcription 5 promotes growth of human prostate cancer cells in vivo. Clin Cancer Res. 2008 Mar 01; 14(5):1317-24.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support